Primary Analysis of Phase 2 Results for Cemiplimab in Patients (pts) with Locally Advanced Basal Cell Carcinoma (laBCC) who Progress on or are Intolerant to Hedgehog Inhibitors (HHIs) Alexander J. Stratigos , Aleksandar Sekulic , Ketty Peris , Oliver Bechter , Martin Kaatz , Karl D. Lewis , Nicole Basset-Segiun , Anne Lynn S. Chang , Stephanie Dalle , Almudena Fernandez Orland , Lisa Licitra , Caroline Robert , Claas Ulrich , Axel Hauschild , Michael R. Migden , Reinhard Dummer , Siyu Li , Kosalai Kal Mohan , Ebony Coates , Vladimir Jankovic , Nathalie Flaschi , Emmanuel Okoye , Ioannis D. Bassukas , Carmen Loquai , Vincent De Giorgi , Zeynep Eroglu , Ralf Gutzmer , Jens Ulrich , Susana Puig , Frank Seebach , Gavin Thurston , Israel Lowy , Timothy Bowler , Matthew G. Fury SKIN The Journal of Cutaneous Medicine（2021）
AI 理解论文
溯源树
样例
